(Q43270020)

17 November 2017

Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). (English)

1 reference

17 November 2017

0 references

4

W D Heiss

1 reference

17 November 2017

2

K Herholz

1 reference

17 November 2017

1

C Haense

1 reference

17 November 2017

W J Jagust

3

1 reference

17 November 2017

25 September 2009

1 reference

Dementia and Geriatric Cognitive Disorders

17 November 2017

1 reference

17 November 2017

28

1 reference

17 November 2017

3

1 reference

17 November 2017

259-266

1 reference

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias

17 November 2017

1 reference

12 December 2020

The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults

1 reference

12 December 2020

Cortical abnormalities in Alzheimer's disease.

1 reference

12 December 2020

Severity of vascular dementia is related to volume of metabolically impaired tissue

1 reference

12 December 2020

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

1 reference

12 December 2020

Age, neuropathology, and dementia.

1 reference

12 December 2020

PET studies in dementia

1 reference

12 December 2020

The role of biomarkers in clinical trials for Alzheimer disease

1 reference

12 December 2020

Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.

1 reference

12 December 2020

Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease

1 reference

12 December 2020

Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients

1 reference

12 December 2020

1 reference

12 December 2020

Positron emission tomography imaging in dementia.

1 reference

12 December 2020

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

1 reference

12 December 2020

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

1 reference

12 December 2020

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

12 December 2020

Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease

1 reference

12 December 2020

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

1 reference

12 December 2020

Added Clinical Benefit of Incorporating 2-Deoxy-2-[F]Fluoro-D-Glucose with Positron Emission Tomography into the Clinical Evaluation of Patients with Cognitive Impairment

1 reference

12 December 2020

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

1 reference

12 December 2020

(18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.

1 reference

12 December 2020

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease

1 reference

12 December 2020

Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

1 reference

12 December 2020

Alzheimer's disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia

1 reference

12 December 2020

Clinical symptoms associated with age at onset in Alzheimer's disease

1 reference

12 December 2020

Robustness of multivariate image analysis assessed by resampling techniques and applied to FDG-PET scans of patients with Alzheimer's disease

1 reference

12 December 2020

FDG PET imaging in patients with pathologically verified dementia.

1 reference

12 December 2020

A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET

1 reference

12 December 2020

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

1 reference

12 December 2020

Hippocampal hypometabolism predicts cognitive decline from normal aging

1 reference

12 December 2020

On the multivariate nature of brain metabolic impairment in Alzheimer's disease.

1 reference

12 December 2020

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

12 December 2020

Greater abnormalities of brain cerebrospinal fluid volumes in younger than in older patients with Alzheimer's disease.

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

1 reference

12 December 2020

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

1 reference

12 December 2020

Identifiers

DOI

10.1159/000241879

1 reference

17 November 2017

0 references

1 reference

PubMed ID

19786778